{"article_url":"https://newsverum.com/tr/news/egypt-localizes-pcv20-vaccine-technology-with-minhai-agreement","block":{"columns":[{"key":"fact","label":{"ar":"المعلومة","de":"Sachverhalt","en":"Fact","es":"Dato","fr":"Fait","pt":"Fato","tr":"Bilgi"},"language":"en","type":"text"},{"key":"finding","label":{"ar":"النتيجة الواردة في المصدر","de":"Von der Quelle gemeldeter Befund","en":"Source-reported finding","es":"Hallazgo comunicado por la fuente","fr":"Constat rapporté par la source","pt":"Informação relatada pela fonte","tr":"Kaynakta bildirilen bulgu"},"language":"en","type":"text"}],"description":{"ar":"اتفاق GennVax–Minhai كما أعلنته هيئة الدواء المصرية","de":"Vereinbarung zwischen GennVax und Minhai laut Mitteilung der Arzneimittelbehörde","en":"GennVax–Minhai agreement as announced by EDA","es":"Acuerdo GennVax–Minhai anunciado por la EDA","fr":"Accord GennVax–Minhai annoncé par l’EDA","pt":"Acordo GennVax–Minhai conforme anunciado pela EDA","tr":"EDA’nın duyurduğu GennVax–Minhai anlaşması"},"id":"d-egypt-localizes-pcv20-vaccine-technolo","methodology":{"ar":"الاتفاق المعلن ينقل تكنولوجيا تصنيع PCV-20؛ لم يُذكر موعد بدء الإنتاج أو حجمه.","de":"Die angekündigte Vereinbarung überträgt die Herstellungstechnologie für PCV-20; ein Produktionsbeginn oder -volumen wurde nicht genannt.","en":"The announced agreement transfers PCV-20 manufacturing technology; no production start date or volume was stated.","es":"El acuerdo anunciado transfiere tecnología de fabricación de PCV-20; no se indicó fecha ni volumen de producción.","fr":"L’accord annoncé porte sur la technologie de fabrication PCV-20; aucune date ni aucun volume de production n’ont été indiqués.","pt":"O acordo anunciado transfere a tecnologia de fabricação da PCV-20; não foi informada data de início nem volume de produção.","tr":"Açıklanan anlaşma PCV-20 üretim teknolojisinin aktarımını kapsar; üretimin başlangıç tarihi veya hacmi belirtilmemiştir."},"rowTranslations":[{"fact":{"ar":"الشريك المصري","de":"Ägyptischer Partner","en":"Egyptian partner","es":"Socio egipcio","fr":"Partenaire égyptien","pt":"Parceiro egípcio","tr":"Mısırlı ortak"},"finding":{"ar":"GennVax","de":"GennVax","en":"GennVax","es":"GennVax","fr":"GennVax","pt":"GennVax","tr":"GennVax"}},{"fact":{"ar":"الشريك الصيني","de":"Chinesischer Partner","en":"Chinese partner","es":"Socio chino","fr":"Partenaire chinois","pt":"Parceiro chinês","tr":"Çinli ortak"},"finding":{"ar":"Minhai","de":"Minhai","en":"Minhai","es":"Minhai","fr":"Minhai","pt":"Minhai","tr":"Minhai"}},{"fact":{"ar":"التكنولوجيا المشمولة","de":"Abgedeckte Technologie","en":"Technology covered","es":"Tecnología comprendida","fr":"Technologie couverte","pt":"Tecnologia abrangida","tr":"Kapsanan teknoloji"},"finding":{"ar":"تصنيع لقاح المكورات الرئوية PCV-20","de":"Herstellung des Pneumokokkenimpfstoffs PCV-20","en":"PCV-20 pneumococcal vaccine manufacturing","es":"Fabricación de la vacuna antineumocócica PCV-20","fr":"Fabrication du vaccin antipneumococcique PCV-20","pt":"Fabricação da vacina pneumocócica PCV-20","tr":"Pnömokok aşısı PCV-20 üretimi"}},{"fact":{"ar":"الإطار الاستراتيجي المعلن","de":"Angekündigter strategischer Rahmen","en":"Announced strategic framework","es":"Marco estratégico anunciado","fr":"Cadre stratégique annoncé","pt":"Estrutura estratégica anunciada","tr":"Duyurulan stratejik çerçeve"},"finding":{"ar":"الاستراتيجية الوطنية المصرية لتصنيع اللقاحات، 2024–2030","de":"Ägyptische nationale Impfstoffherstellungsstrategie, 2024–2030","en":"Egypt national vaccine manufacturing strategy, 2024–2030","es":"Estrategia nacional de fabricación de vacunas de Egipto, 2024–2030","fr":"Stratégie nationale égyptienne de fabrication de vaccins, 2024–2030","pt":"Estratégia nacional de fabricação de vacinas do Egito, 2024–2030","tr":"Mısır Ulusal Aşı Üretim Stratejisi, 2024–2030"}}],"rows":[{"fact":"Egyptian partner","finding":"GennVax"},{"fact":"Chinese partner","finding":"Minhai"},{"fact":"Technology covered","finding":"PCV-20 pneumococcal vaccine manufacturing"},{"fact":"Announced strategic framework","finding":"Egypt national vaccine manufacturing strategy, 2024–2030"}],"sourceUrls":["https://sis.gov.eg/en/media-center/news/gennvax-minhai-sign-deal-to-transfer-pneumococcal-vaccine-technology/"],"title":{"ar":"اتفاق نقل تكنولوجيا لقاح PCV-20","de":"Vereinbarung zum Technologietransfer für den PCV-20-Impfstoff","en":"PCV-20 vaccine technology transfer agreement","es":"Acuerdo de transferencia de tecnología de la vacuna PCV-20","fr":"Accord de transfert de technologie du vaccin PCV-20","pt":"Acordo de transferência de tecnologia da vacina PCV-20","tr":"PCV-20 aşısı teknoloji transferi anlaşması"},"type":"table","updatedAt":"2026-10-12T06:24:22+03:00"},"version":1}
